| # | Drug | Count |
|---|---|---|
| 0 | RIBOCICLIB | 40 |
| 1 | LETROZOLE | 21 |
| 2 | FULVESTRANT | 19 |
| 3 | DENOSUMAB | 13 |
| 4 | LETROZOLE TABLETS | 13 |
| 5 | PALBOCICLIB | 13 |
| 6 | ANASTROZOLE | 12 |
| 7 | OCTREOTIDE ACETATE | 12 |
| 8 | DEXAMETHASONE | 11 |
| 9 | DEXAMETHASONE 1.5 MG | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RIBOCICLIB | 40 | 0.0012 |
| 1 | IXABEPILONE | 1 | 0.0010 |
| 2 | TRIPTORELIN PAMOATE | 2 | 0.0008 |
| 3 | ABROCITINIB | 3 | 0.0008 |
| 4 | STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM | 1 | 0.0007 |
| 5 | ERLOTINIB HYDROCHLORIDE | 8 | 0.0006 |
| 6 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 7 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 8 | SARGRAMOSTIM | 1 | 0.0006 |
| 9 | FULVESTRANT | 19 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 45 |
| 1 | Aromatase Inhibitor [EPC] | 37 |
| 2 | Estrogen Receptor Antagonist [EPC] | 22 |
| 3 | Corticosteroid [EPC] | 21 |
| 4 | Proton Pump Inhibitor [EPC] | 15 |
| 5 | Platinum-based Drug [EPC] | 14 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 7 | RANK Ligand Inhibitor [EPC] | 13 |
| 8 | Benzodiazepine [EPC] | 11 |
| 9 | Opioid Agonist [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 22 | 0.0005 |
| 1 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Aromatase Inhibitor [EPC] | 37 | 0.0003 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 5 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 6 | Allylamine Antifungal [EPC] | 1 | 0.0001 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 6 | 0.0001 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 8 | 0.0001 |
| 9 | Kinase Inhibitor [EPC] | 45 | 0.0001 |